p53-binding protein 1 (53BP1) is known to be an important mediator of the DNA damage response 1 , with dimethylation of histone H4 lysine 20 (H4K20me2) critical to the recruitment of 53BP1 to double-strand breaks (DSBs) 2,3 . However, it is not clear how 53BP1 is specifically targeted to the sites of DNA damage, as the overall level of H4K20me2 does not seem to increase following DNA damage. It has been proposed that DNA breaks may cause exposure of methylated H4K20 previously buried within the chromosome; however, experimental evidence for such a model is lacking. Here we found that H4K20 methylation actually increases locally upon the induction of DSBs and that methylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or WHSC1) in mammals. Downregulation of MMSET significantly decreases H4K20 methylation at DSBs and the subsequent accumulation of 53BP1. Furthermore, we found that the recruitment of MMSET to DSBs requires the cH2AX-MDC1 pathway; specifically, the interaction between the MDC1 BRCT domain and phosphorylated Ser 102 of MMSET. Thus, we propose that a pathway involving cH2AX-MDC1-MMSET regulates the induction of H4K20 methylation on histones around DSBs, which, in turn, facilitates 53BP1 recruitment.
p53-binding protein 1 (53BP1) is known to be an important mediator of the DNA damage response 1 , with dimethylation of histone H4 lysine 20 (H4K20me2) critical to the recruitment of 53BP1 to double-strand breaks (DSBs) 2, 3 . However, it is not clear how 53BP1 is specifically targeted to the sites of DNA damage, as the overall level of H4K20me2 does not seem to increase following DNA damage. It has been proposed that DNA breaks may cause exposure of methylated H4K20 previously buried within the chromosome; however, experimental evidence for such a model is lacking. Here we found that H4K20 methylation actually increases locally upon the induction of DSBs and that methylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or WHSC1) in mammals. Downregulation of MMSET significantly decreases H4K20 methylation at DSBs and the subsequent accumulation of 53BP1. Furthermore, we found that the recruitment of MMSET to DSBs requires the cH2AX-MDC1 pathway; specifically, the interaction between the MDC1 BRCT domain and phosphorylated Ser 102 of MMSET. Thus, we propose that a pathway involving cH2AX-MDC1-MMSET regulates the induction of H4K20 methylation on histones around DSBs, which, in turn, facilitates 53BP1 recruitment.
In response to DNA damage, 53BP1 rapidly relocalizes to the sites of DNA lesions in a phospho-H2AX (cH2AX)-and MDC1-dependent manner [4] [5] [6] [7] . 53BP1 is also recruited to the sites of DNA damage through a second mechanism that involves the binding of the tandem tudor domains of 53BP1 to methylated histones, with dimethylated H4K20 (H4K20me2) being the known physiological binding site for both mammalian 53BP1 and its yeast homologue Crb2 2,3 . However, unlike H2AX phosphorylation, no increase in the total levels of H4K20me2 was observed after DNA damage 2, 3 . It is also not clear whether 53BP1 damage recruitment regulated by H2AX phosphorylation and H4K20 methylation are separate pathways or if they are interconnected. Studies from Schizosaccharomyces pombe showed that disruption of both H4K20 methylation and H2AX phosphorylation does not cause synergistic or additive effects on the DNA damage response, indicating that they might function in the same pathway 8 .
We examined H4K20 methylation at the sites of DNA damage using the cellular system (a HeLa clone carrying the DR-GFP homologous recombination reporter), in which expression of exogenous I-SceI introduces a single DSB in the cell's genome 9 . After I-SceI induction of DSBs, chromatin was immunoprecipitated from the cells using antibodies directed against mono-, di-or trimethylated H4K20 (H4K20me1/2/3), and quantitative polymerase chain reaction (qPCR) was used to determine the relative abundance of H4K20me1/2/3 at the induced break sites, while standard PCR gave a visual representation of the relative accumulation of these proteins at the DSB sites. Interestingly, H4K20me1/2/3 at the I-SceI break site all increased after DSB induction ( Fig. 1a, b) , as did the H4K20me2 signal at the sites of DNA damage induced by laser irradiation (Fig. 1c ). Consistent with previous reports, we did not observe apparent increase in total H4K20me2 levels 2,3 by western blot at commonly used ionizing radiation doses (Supplementary Fig. 1a ), but we did observe a notable increase following high doses of ionizing radiation. This indicates that local increases of H4K20me2 at DSBs induced by low doses of ionizing radiation are masked from detection by western blotting owing to the high basal levels of H4K20me2 occurring throughout the genome.
Next we investigated how the increase of H4K20me2/3 was induced at DSBs. It has been proposed that SET8 is mainly responsible for H4K20me1 10, 11 , which is required for subsequent di-and trimethylation of H4K20. SUV420H1 and SUV420H2 are the major enzymes responsible for H4K20me2 and H4K20me3, respectively 12, 13 . However, despite SUV420H1/2 loss and the subsequent lack of most H4K20me2/ 3, 53BP1 accumulation at DSBs was not abolished and only slightly delayed 13 . We did not observe substantial accumulation of SUV420H1 at the DSBs, whereas small amounts of SET8 localized to the I-SceI site both before and after DNA cleavage ( Fig. 1d, e ). This indicates that other histone methyltransferases methylate H4K20 specifically at DSBs. Interestingly, we found that MMSET, a newly identified histone methyltransferase [14] [15] [16] , accumulated at DSBs (Fig. 1d , e and Supplementary Fig. 1b ).
Consistent with the results obtained from chromatin immunoprecipitation (ChIP) assays, MMSET formed discrete foci after ionizing radiation, colocalizing with 53BP1 ( Fig. 1f ). MMSET has been shown to methylate H3K36, H3K27 and H4K20 [14] [15] [16] , and misregulation of MMSET due to haploinsufficiency in Wolf-Hirschhorn syndrome 17 and by t(4;14) chromosome translocation in multiple myeloma 18, 19 indicates that it has an important role in the pathogenesis of these diseases. However, the cellular function of MMSET is largely uncharacterized. Our results imply that MMSET has a role in the DNA damage response ( Fig. 1d-f ). In support of this, downregulation of MMSET resulted in cellular hypersensitivity to ionizing radiation ( Supplementary Fig. 1c ).
We proposed that MMSET regulates the DNA damage response through H4K20 methylation at DSBs. As shown in Fig. 2a, b and Supplementary Fig. 2a , b, downregulation of MMSET significantly decreased H4K20me2/3 at DSBs, but did not significantly affect H4K20me1 or H3K36 methylation at DSBs. We reasoned that if MMSET regulates H4K20me2 at DSBs, then MMSET should regulate the recruitment of 53BP1 to DSBs. Indeed, we found that downregulation of MMSET significantly decreased DNA-damage-induced focus formation of 53BP1, but not cH2AX, MDC1 or RNF8, which are upstream regulators of 53BP1 ( Fig. 2c and Supplementary Fig. 2c,  d ). Further, 53BP1 focus formation was defective in cells overexpressing a truncated MMSET (H929) 15 , whereas in cells expressing fulllength MMSET (KMS11), 53BP1 focus formation was unaffected ( Supplementary Fig. 2e ). Downregulation of 53BP1 did not affect MMSET focus formation ( Fig. 2d ), indicating that MMSET is an upstream regulator of 53BP1. Importantly, downstream signalling events regulated by 53BP1, such as CHK2 phosphorylation 20 
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impaired by downregulation of MMSET ( Fig. 2e and Supplementary Fig. 2f ). To determine whether MMSET methyltransferase activity is required for these processes, we mutated the critical residue (F1117) required for MMSET methyltransferase activity 15 . We reintroduced short hairpin RNA (shRNA)-resistant wild-type MMSET or MMSET(F1117A) to cells stably transfected with MMSET shRNA. As shown in Supplementary Fig. 2g , h, whereas wild-type MMSET restored H4K20 methylation and 53BP1 recruitment to DSBs, MMSET(F1117A) did not. These data indicate that MMSET methylates H4K20 at DSBs, which facilitates the subsequent accumulation of 53BP1.
Previous studies indicated that the accumulation of 53BP1 at sites of DNA damage also requires H2AX and MDC1 [4] [5] [6] [7] . On investigation of this potential connection, we found that MMSET accumulation at DSBs was significantly reduced in cells depleted of H2AX and MDC1 ( Fig. 3a and Supplementary Fig. 3a ), as was H4K20me2 and the accumulation of 53BP1. Further, MDC1 foci appeared earlier than those of MMSET, whereas MMSET foci formed earlier than those of 53BP1 ( Supplementary Fig. 3b ). Thus, the accumulation of MMSET and the subsequent methylation of H4K20 and 53BP1 recruitment at DSBs seem to require H2AX and MDC1.
Previous studies also indicate that downstream of MDC1, the E3 ubiquitin ligase RNF8 regulates 53BP1 foci formation through its role in histone ubiquitination [21] [22] [23] . It is unclear whether RNF8 and MMSET regulate 53BP1 accumulation in parallel or in the same pathway. As shown in Supplementary Fig. 4a , downregulation of RNF8 did not affect MMSET recruitment and H4K20 methylation, although 53BP1 recruitment was compromised. In addition, downregulation of MMSET had no effect on the recruitment of RNF8 to DSBs or the ubiquitination of H2A at DSBs (Fig. 2c, Supplementary Fig. 2c  and 4b ), indicating that RNF8 and MMSET function in distinct pathways. Thus, the mechanism through which RNF8-mediated ubiquitination events regulate 53BP1 recruitment remains to be determined.
While investigating how the H2AX-MDC1 pathway regulates MMSET accumulation at DSBs, we found that MMSET interacted with MDC1 in a DNA-damage-inducible manner (Fig. 3b) . The interaction seemed to be specific to the MDC1 BRCT domain, as the BRCA1 BRCT domain and the MDC1 BRCT-domain mutant K1936M 24 were unable to interact ( Fig. 3c and Supplementary Fig.  4c) ). Because BRCT domains recognize phospho-Ser/Thr motifs 25, 26 , it is likely that MMSET is phosphorylated following DNA damage, thereby facilitating its interaction with MDC1. As shown in Supplementary Fig. 4d , MMSET was phosphorylated at ATM consensus SQ/TQ sites after ionizing radiation. No phospho-SQ/TQ signal was detected in ATM-deficient MEF cells or in samples treated with l-phosphatase, indicating that MMSET is phosphorylated in an ATM-dependent manner. A previous large-scale proteomic study demonstrated that Ser 102 of MMSET is phosphorylated by ATM after 
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DNA damage 27 . As shown in Fig. 3d , mutation at S102 abolished ATM-dependent MMSET phosphorylation after DNA damage, indicating that S102 is the major ATM phosphorylation site of MMSET. Further, mutation at S102 abolished the MDC1-MMSET interaction (Fig. 3e) , verifying that the phosphorylation of S102 is required for MDC1 binding. The MDC1 BRCT domain has been shown to bind phospho-139 (pS 139 QEY) of cH2AX, and a carboxy-terminal Y at the 13 position is critical for the binding specificity, although E at 12 is also positively selected 24, 28 . The MMSET sequence after S102 is QEM, and does not contain Y at the 13 position. To confirm further the specificity of the MDC1-MMSET interaction, we used peptides containing either S102 or phospho-S102 to perform several assays. As shown in Supplementary Fig. 4e , phosphopeptides of MMSET preferentially pulled-down endogenous MDC1 from cell lysates. We determined further the binding affinity between MMSET peptides and the MDC1 BRCT domain using surface plasmon resonance (SPR). We found that the MDC1 BRCT domain preferentially bound MMSET phosphopeptides (K d 5 893 nM), although with a lower affinity than it did cH2AX peptides (K d 5 287 nM). No MDC1 binding was found for non-phosphopeptides of MMSET (Fig. 3f) .
To investigate the functional significance of MMSET phosphorylation, we stably transfected HeLa DR-GFP cells with MMSET shRNA, and reconstituted these cells with shRNA-resistant wild-type MMSET or the MMSET(S102A) mutant. As shown in Fig. 4a, b and Supplementary Fig. 5a , wild-type MMSET was recruited to DSBs, but the recruitment of MMSET(S102A) was defective. This indicates that S102 phosphorylation and the MDC1-MMSET interaction are essential for MMSET accumulation at DSBs. Similarly, reconstitution of wild-type MMSET, but not MMSET(S102A), rescued H4K20me2/ 3, 53BP1 accumulation at DSBs and CHK2 phosphorylation (Fig. 4a, c and Supplementary Fig. 5a-d) . It is possible that the S102A mutation affects MMSET methyltransferase activity and subsequent H4K20 methylation. However, we found that the activity of MMSET and MMSET(S102A) towards histone H4 is comparable before and after ionizing radiation, indicating that the effects described earlier caused by S102A mutation are not due to a decreased methyltransferase activity ( Supplementary Fig. 5e, f) .
The BRCT domain of MDC1 is required for binding to cH2AX at DNA damage sites, but it is unclear whether MDC1 uses this same domain to recruit MMSET to DSBs. We found that MDC1 formed oligomers ( Supplementary Fig. 5g ) and DNA damage increased the oligomerization of MDC1 ( Supplementary Fig. 5h ). Therefore, it is likely that different molecules in the MDC1 multimers bind cH2AX and MMSET separately at the DNA damage sites.
Lastly, to examine how MMSET phosphorylation ultimately affects cellular sensitivity to DNA damage, we performed colony formation assays. Depletion of MMSET resulted in a significant increase in ionizing radiation sensitivity (Fig. 4d ), and reconstitution with wild-type MMSET could reverse this effect whereas MMSET(S102A) could not.
Our studies reveal a critical role of the methyltransferase MMSET in regulating the assembly of 53BP1 foci at DNA lesions (Fig. 4e ). We show that H4K20 methylation, unlike the previously held view, is 
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induced at DSBs. We also establish a previously unrecognized link between the H2AX-MDC1 pathway and H4K20 methylation, and show that MMSET connects these two pathways. These results indicate that multiple myeloma tumours with t(4;14) translocation and MMSET dysregulation may have aberrant responses to DNA damage, which may be related to the poor prognosis observed in this subgroup of patients that are treated with DNA alkylating agents.
METHODS SUMMARY
HeLa DR-GFP and MDA-MB-231 ROS8 cell lines were used for the ChIP assays, which were subsequently analysed by PCR or qPCR. Co-immunoprecipitation was used to detect protein-protein interactions in vivo and SPR was used to detect the affinity for the protein and peptide interaction in vitro. Transient transfection of short interfering RNA (siRNA) or stable downregulation by shRNA was used to decrease the level of specific proteins. Immunofluorescence staining was used to visualize protein accumulation and localization after DNA damage. 
METHODS
Plasmids and shRNAs. The MMSET(S102A) mutant was generated by PCR-based site-directed mutagenesis against full-length MMSET (pCEFL-MMSET-II). Wildtype MMSET or MMSET(S102A) was cloned into a pIRES2 vector containing S-and Flag-tag. shRNA-resistant constructs were made by introducing a silent mutation at the MMSET coding region (1666-1671; CTTCGG to CTGCGA). The MDC1 FHA and BRCT domains were cloned into the pGEX4T-1 vector for bacterial expression of GST fusion proteins.
MMSET shRNA 1: 59-GCACGCTACAACACCAAGTTT; MMSET shRNA 2: 59-GCACAGTCTTCGGAAGAGAGACACAATCA; control shRNA: 59-TTCAA TAAATTCTTGAGGT; MDC1 siRNA (MDC1 cDNA 58-76): UCCAGUGAA UCCUUGAGGUdTdT; control siRNA: UUCAAUAAAUUCUUGAGGUdTdT; H2AX siRNA: CAACAAGAAGACGCGAAUCdTdT; 53BP1 siRNA: 59-AA GAUACUCCUUGCC UGAUAA-39; RNF8 siRNA: 59-AGAAUGAGCUCC AAUGUAUUU-39. Antibodies and cell lines. MMSET antibodies were provided by J. D. Licht or purchased from Abcam. Commercial antibodies used for ChIP were obtained from Upstate biotechnology (cH2AX mouse monoclonal), Millipore (H4, H4K20me1/ 2/3, H2AUb), Active Motif (H4K20me2) and Novus (rabbit 53BP1). Antibodies against p53, pSQ/TQ, phospho-CHK2, CHK1 and phospho-CHK1 were purchased from Cell Signaling. CHK2 antibody was purchased from Millipore. RNF8 antibody was purchased from Abcam. MDC1 antibodies have been previously described 6 .
293T cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS). HCT116 and U2OS cells were cultured in DMEM supplemented with 10% FBS. HeLa DR-GFP cell lines were cultured in DMEM supplemented with 10% FBS and 2 ng ml 21 puromycin. Mouse embryonic fibroblasts (MEFs) were cultured in DMEM containing 10% FBS and 5% ES. Immunoprecipitation, immunoblotting, and in vitro pull-down assays. We prepared cell lysates, performed immunoprecipitation, and immunoblotting as previously described 29 . GST fusion proteins were bound to glutathione sepharose overnight at 4 uC. The beads were washed with PBS twice and incubated with cell lysates for 3 h at 4 uC. Beads were then washed with NETN buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40) three times, and proteins bound to beads were eluted by SDS sample buffer (100 uC for 12 min) and separated by SDS-PAGE for western blot analysis. Immunofluorescence staining. Cells grown on coverslips were fixed with 3% paraformaldehyde solution in 13 PBS containing 50 mM sucrose at room temperature (22 uC) for 15 min. After permeabilization with 0.5% Triton X-100 buffer containing 20 mM HEPES pH 7.4, 50 mM NaCl, 3 mM MgCl 2 and 300 mM sucrose at room temperature for 5 min, cells were blocked with 5% goat serum for 1 h at room temperature, then incubated with primary antibodies at 37 uC for 20 min. After washing with PBS twice, cells were incubated with FITC or rhodamineconjugated secondary antibodies at 37 uC for 20 min. Nuclei were counterstained with 49,6-diamidino-2-phenylindole (DAPI). After a final wash with PBS, coverslips were mounted with glycerin containing paraphenylenediamine. ChIP. Induction of a single DSB in HeLa DR-GFP cells was performed through transfection of the I-SceI expression plasmid. Twenty-four hours after transfection, about 5 3 10 7 cells were treated with 1% formaldehyde for 10 min at room temperature to crosslink proteins to DNA. Glycine (0.125 M) was added and incubated at room temperature for 5 min to stop the cross-linking. Cells were harvested and the pellets were resuspended in cell lysis buffer (5 mM PIPES (KOH), pH 8.0, 85 mM KCl, 0.5% NP-40) containing the following protease inhibitors: 1 mg ml 21 leupeptin, 1 mg ml 21 aprotinin and 1 mM PMSF; and incubated for 10 min on ice. Nuclei were pelleted by centrifugation (2,200g for 5 min). Nuclei were then resuspended in nuclear lysis buffer (50 mM Tris, pH 8.1, 10 mM EDTA, 1% SDS containing the same protease inhibitors as in cell lysis buffer) and sonicated to shear chromatin to an average size of 0.6 kb. Once centrifuged until clear, the lysates were precleared overnight with salmon sperm DNA/protein-A agarose slurry. Twenty per cent of each supernatant was used as input control and processed with the cross-linking reversal step. The rest of the supernatant (about 80% of the total) was incubated with 5 mg of the indicated antibody overnight at 4 uC with rotation. Complexes were washed four times, once in high salt buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, 0.1% SDS, 0.5% deoxycholate, 1% NP-40, 1 mM EDTA), once in LiCl buffer (50 mM Tris-HCl, pH 8.0, 250 mM LiCl, 1% NP-40, 0.5% deoxycholate, 1 mM EDTA) and twice in TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, pH 8.0). Beads were resuspended in TE containing 50 mg ml 21 of RNase and incubated for 30 min. Beads were washed with water and elution buffer (1% SDS, 0.1 M NaHCO 3 ) was added for 15 min. Crosslinks were reversed by adding 10 mg ml 21 RNase and 5 M NaCl to a final concentration of 0.3 M to the elutants and incubated in a 65 uC water bath for 4-5 h. Two volumes of 100% ethanol were added to the precipitate overnight at 220 uC. DNA was pelleted and resuspended in 100 ml of water, 2 ml of 0.5 M EDTA, 4 ml 1 M Tris, pH 6.5, and 1 ml of 20 mg ml 21 Proteinase K was added and incubated for 1-2 h at 45 uC. DNA was then purified and used in PCR reactions.
The PCR primers for ChIP, about 220 bp away from the I-SceI cut site, were as follows: forward, 59-TACAGCTCCTGGGCAACGTG-39; reverse, 59-TCCTGCT CCTGGGCTTCTCG-39.
Amplification was performed using the following program: 95 uC for 5 min, 1 cycle; 95 uC for 45 s, 56 uC for 30 s and 72 uC for 30 s, 30 cycles; 72 uC for 10 min, 1 cycle. A total of 12.5 ml of the PCR products was applied to a 1.2% agarose gel and visualized by ethidium bromide staining. Quantitative analysis of ChIP samples. qPCR was performed on a 7500 RT-PCR System (Applied Biosystems) using the SYBR Green detection system with the following program: 95 uC for 5 min, 1 cycle; 95 uC for 45 s and 62 uC for 45 s, 40 cycles. As an internal control for the normalization of the specific fragments amplified, a locus outside the region of the DSB was amplified, in this case FKBP5, using the input control sample as template. The internal control
